Hip fractures in elderly patients
Conditions
Interventions
Experimental group:Single dose bupivacaine liposome 266mg iliac fascia block
Control group:Single dose 0.375% ropivacaine 20-30ml iliac fascia block
Sponsors
Jiangsu University Affiliated Hospital
Eligibility
Sex/Gender
All
Age
65 Years to 99 Years
Inclusion criteria
Inclusion criteria: ? Patients with hip fractures who are scheduled for elective surgery, including total hip replacement, semi hip replacement, PFNA (proximal femoral anti rotation intramedullary nail fixation), and the American Society of Anesthesiologists (ASA) grade II-III; ? Age = 65 years old, BMI 18-25; ? Agree to receive a preventive analgesic plan; ? Voluntary participation in research.
Exclusion criteria
Exclusion criteria: ? Preoperative visits revealed significant cognitive impairment with MMSE scores (see Appendix 2). Illiteracy<17 points, primary school<20 points, and middle school and above<24 points; ? History of hip surgery; ? History of opioid or alcohol abuse; ? History of chronic pain; ? Neurological disorders; ? Severe visual impairment; ? Anemia (Hb < 80g/L), coagulation disorders; ? Unable to communicate effectively with doctors verbally; ? Voluntary withdrawal from the study midway; ? Preoperative patients with basic diseases such as heart failure, seriously decreased respiratory function, severe arrhythmia, and poorly controlled hypertension and diabetes.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain;PCIA Press Times;Remedial analgesia frequency; | — |
Secondary
| Measure | Time frame |
|---|---|
| delirium;sleep quality; | — |
Countries
China
Contacts
Public ContactJiang Peng
Jiangsu University Affiliated Hospital
Outcome results
None listed